On October 5, 2017, the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare, Republic of China announced that Shinsheng Enterprise Co., Ltd., the distributor of “HIDONAC INJECTION”, voluntarily initiated a product recall after the manufacturer reported that the expiration dates printed on the outer packaging box and the vial label were inconsistent.
Basic Information of Recalled Medication:
- Product Name: HIDONAC INJECTION (希那克注射劑)
- Indications: Antidote for intentional or accidental PARACETAMOL[ii] poisoning.
- Active Ingredient: ACETYLCYSTEINE
- License Number: DOH-MD-No. 024213
- Batch Number: 20022657
- License Holder: Shinsheng Enterprise Co., Ltd.

Recall Details
- Official Dispatch No.: FDA-Yao-Zi No. 1060038620 (TFDA Medicinal Products Division)
- Dispatch Date: September 27, 2017
- Announcement Date: October 5, 2017
- Reason for Recall: Voluntary report by the manufacturer that the expiration dates printed on the outer box and the vial label of the specified batch were inconsistent.
Further Reading
- Introduction to the TFDA Drug Recall Classification System and Disposal Measures
- Paracetamol (also known as Acetaminophen or APAP) is a widely used over-the-counter analgesic and antipyretic medication commonly utilized to relieve headaches and mild-to-moderate pain, and is a standard ingredient in many cold and flu remedies.
Support Independent Perspectives & In-Depth Insights
Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.
Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.
Payments secured by Google · Manage or cancel anytime in your Google Account

Comments